Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure
- 12 January 2018
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 58 (5) , 628-639
Abstract
Mycophenolic acid (MPA) is an approved immunosuppressive agent widely prescribed to prevent rejection after kidney transplantation. Wide between‐subject variability (BSV) in MPA exposure exists which in part may be due to variability in enterohepatic recirculation (EHC). Several modeling strategies were developed to evaluate EHC as part of MPA pharmacokinetics, however mechanistic representation of EHC is limited. These models have not provided a satisfactory representation of the physiology of EHC in their modeling assumptions. The aim of this study was i) to develop an integrated model of MPA (total and unbound) and its metabolites (MPAG and acyl‐MPAG) in kidney recipients, where this model provides a more physiological representation of EHC process, and ii) to evaluate the effect of donor and recipient clinical covariates and genotypes on MPA disposition. A five‐compartment model with first‐order input into an unbound MPA compartment connected to the MPAG, acyl‐MPAG, and gallbladder compartment best fit the data. To represent the EHC process, the model was built based on the physiological concepts related to the hepatobiliary system and the gallbladder filling and emptying processes. The effect of cyclosporine versus tacrolimus on clearance of unbound MPA was included in the base model. Covariate analysis showed creatinine clearance to be significant on oral clearance of unbound MPA. The hepatic nuclear factor 1 alpha (HNF1A) genetic single nucleotide polymorphism (SNP) (rs2393791) in the recipient significantly affected the fraction of enterohepatically‐circulated drug. Oral clearance of MPAG was affected by recipient IMPDH1 SNP (rs2288553), diabetes at the time of transplant, and donor sex.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (U19‐AI070119, U01‐AI058013)
This publication has 52 references indexed in Scilit:
- Nonlinear Relationship between Mycophenolate Mofetil Dose and Mycophenolic Acid ExposureClinical Journal of the American Society of Nephrology, 2011
- Diabetes Mellitus Reduces Activity of Human UDP-Glucuronosyltransferase 2B7 in Liver and Kidney Leading to Decreased Formation of Mycophenolic Acid Acyl-Glucuronide MetaboliteDrug Metabolism and Disposition, 2011
- The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune DiseaseClinical Pharmacokinetics, 2011
- Population Pharmacokinetics of Mycophenolic Acid and Metabolites in Patients With GlomerulonephritisTherapeutic Drug Monitoring, 2010
- Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipientsJournal of Pharmacokinetics and Pharmacodynamics, 2009
- Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9British Journal of Clinical Pharmacology, 2008
- Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant RecipientsClinical Pharmacokinetics, 2007
- A haplotype map of the human genomeNature, 2005
- Estimation of area under the curve for drugs subject to enterohepatic cyclingJournal of Pharmacokinetics and Biopharmaceutics, 1985
- Abnormal gallbladder emptying in patients with gallstonesDigestive Diseases and Sciences, 1982